Company / Goodwill
Matinas BioPharma Holdings, Inc. Goodwill History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$1.3M
FY2023
5-year range
$1.3M / $1.3M
FY2019-FY2023
Trend
+0.0%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Goodwill remained relatively stable over the past 9 years, with values between $1M and $1M.
Based on SEC 10-K filings.
$1M in FY2023 with a 5-year CAGR of -0.0%.
Remained stable around $1M over the past 2 years.
Goodwill over time
Growth rates
- 3-Year CAGR
- -0.0%
- 5-Year CAGR
- -0.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -0.0%, indicating a declining trend.
- In FY2023, goodwill increased 0.0% year-over-year.
- Peak goodwill was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | $1.3M | +0.0% |
| FY2022 | $1.3M | +0.0% |
| FY2021 | $1.3M | -0.0% |
| FY2020 | $1.3M | +0.0% |
| FY2019 | $1.3M | +0.0% |
| FY2018 | $1.3M | +0.0% |
| FY2017 | $1.3M | +0.0% |
| FY2016 | $1.3M | +0.0% |
| FY2015 | $1.3M | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026